Development and Justification of Therapeutic Approaches for Abnormal Uterine Bleeding in Puberty
PDF

Keywords

Adolescent gynecology; Menorrhagia; Hemostatic stabilization; Tranexamic acid; Hypothalamic-pituitary-ovarian axis; Von Willebrand disease.

How to Cite

Diyora Pulatova. (2026). Development and Justification of Therapeutic Approaches for Abnormal Uterine Bleeding in Puberty. INTERNATIONAL CONFERENCE ON SCIENCE, INNOVATION AND GLOBAL DEVELOPMENT, 1(5), 274-279. https://doi.org/10.5281/zenodo.20387856

Abstract

Pubertal abnormal uterine bleeding requires highly specialized, non-adult-centric intervention strategies to mitigate rapid hemodynamic collapse and preserve pediatric reproductive architecture. This condensed prospective analysis evaluates targeted pharmacological protocols across a rigorously phenotyped cohort of 312 adolescent females (aged 11-17) treated between 2020 and 2024. Diagnostic mapping isolated neuroendocrine immaturity (65.4%) and latent hereditary coagulopathies (19.2%) as the primary etiological drivers. By stratifying 118 acute emergency cases and 194 chronic outpatient cases, the investigation measured the precise kinetic advantages of etiology-specific therapies. Deploying synchronous intravenous tranexamic acid and high-dose progestins secured complete acute hemostasis within 36 hours for 84.6% of hospitalized subjects, bypassing surgical intervention. Extended-cycle monophasic oral contraceptives maintained long-term stabilization in 91.2% of the chronic cohort. The statistical outcomes absolutely invalidate empirical, generalized hormonal suppression, dictating the immediate adoption of step-wise, hematologically verified algorithms for adolescent gynecological care.

PDF

References

1. Deligeoroglou E, Karountzos V. Management of abnormal uterine bleeding in adolescents: a comprehensive review. Pediatr Endocrinol Rev. 2021;18(3):234-245.

2. Mullins E, Gurtcheff S, Rebar R. The neuroendocrine regulation of the pubertal transition and its clinical implications. J Pediatr Adolesc Gynecol. 2022;35(2):112-120.

3. James AH. Heavy menstrual bleeding in adolescents with bleeding disorders. Haemophilia. 2020;26(1):15-22.

4. American College of Obstetricians and Gynecologists. Committee Opinion No. 785: Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. Obstet Gynecol. 2019;134(3):e71-e83.

5. Chi C, Kadir RA. Inherited bleeding disorders in the adolescent female. Best Pract Res Clin Obstet Gynaecol. 2020;63:45-58.

6. O'Brien SH, Zia A. Menorrhagia in adolescents: an algorithmic approach to diagnosis and management. Pediatr Clin North Am. 2022;69(4):725-738.

7. Pecchioli Y, Quint E, Gomez-Lobo V. The utilization of tranexamic acid in pediatric and adolescent gynecology. J Pediatr Adolesc Gynecol. 2023;36(1):14-19.

8. Rimmer E, Rance E, Roberts L. High-dose progestin therapy for acute abnormal uterine bleeding: a clinical analysis. Int J Gynaecol Obstet. 2021;154(2):205-211.

9. Srivaths LV, Minard CG, O'Brien SH. Heavy menstrual bleeding in adolescents: establishing standardized criteria for hospital admission. Blood Adv. 2020;4(15):3677-3684.

10. FIGO Menstrual Disorders Committee. FIGO guidelines on the management of abnormal uterine bleeding. Int J Gynaecol Obstet. 2023;162(2):380-395.

Downloads

Download data is not yet available.